|View printer-friendly version|
|Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008|
BOULDER, Colo.--(BUSINESS WIRE)--April 30, 2008--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2008 on Monday, May 5, 2008, and will hold a conference call on Tuesday, May 6, 2008, at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
Conference Call Information
A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 3440191.
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory diseases and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies access Array's drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.